Clinical Trial Update: Study to Evaluate the Safety, Tolerability, Preliminary Efficacy and Pharmacokinetics of Simmitecan Monotherapy and Combination in Patients With Advanced Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 trial update evaluating Simmitecan as monotherapy and in combination in patients with advanced colorectal cancer; the study status is currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Simmitecan

Snippet

Sponsor: Haihe Biopharma Co., Ltd. | Conditions: Advanced Solid Tumor, Advanced/Metastatic Colorectal Cancer | Phase 1 | Status: UNKNOWN